|
Prior to joining OVATION Pharmaceuticals in 2002, Marc Wipperman was with Chiron Corporation (previously PathoGenesis Corporation). Though Mr. Wipperman began his tenure as Senior Vice President of Operations, he also held the title of Vice President for Chiron's BioPharmaceuticals Unit. In that role, he led the successful integration of key commercial operations between Chiron and PathoGenesis in 2001. From 1974 to 1993, Mr. Wipperman worked for Johnson & Johnson at both worldwide headquarters and its operating companies, including the McNeil Pharmaceutical, Ortho Pharmaceutical and Ortho Diagnostics companies. Mr. Wipperman's background includes a broad range of domestic and international capacities, encompassing pharmaceutical development, manufacturing and quality assurance, distribution and customer service. | 